AVAH on Nasdaq
Aveanna Healthcare Holdings, Inc.
American home health care services company based in Atlanta2
In its 2026 annual report the company says: “We are a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations. Our patient-centered care delivery platform is designed to improve the quality of care our patients receive, which allows them to remain in their homes and minimizes the overutilization of high-cost care settings such as hospitals.”6 Its shares trade on Nasdaq under the symbol AVAH.2
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with Chemed Corporation, AdaptHealth Corp. or Addus HomeCare Corp, or pick any stock.
- TickerAVAH on Nasdaq2
- IndustryServices-Home Health Care Services2
- HeadquartersAtlanta, United States2
- Incorporated inDE4
- Business address400 Interstate North Parkway, Ste 1700, Atlanta, Ga 303394
- Filer categoryAccelerated filer4
- Legal formLimited Liability Company2
- LEI5493006D6JRLPIY8YV182
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O Corporation Service Company, 19808 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 62493262
See how the biggest companies compare on our leaderboards
Aveanna is a Delaware corporation and was incorporated on November 30, 2016, originally under the name BCPE Oasis Holdings Inc. Aveanna commenced operations in March 2017 in connection with the transformative merger of Epic Health Services Inc. and Pediatric Services of America, Inc. in March 2017 under the name BCPE Eagle Holdings Inc. On May 26, 2017, we changed our name to Aveanna Healthcare Holdings Inc. and commenced trading on the Nasdaq Stock Market on April 29, 2021. Our principal executive offices are located at 400 Interstate North Parkway SE, Suite 1600, Atlanta, Georgia and our phone number is (770) 441-1580. We maintain a website at www.aveanna.com. Information contained on, or accessible through, our website is not a part of and is not incorporated by reference into this Annual Report on Form 10-K.6 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2026
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Private Duty Services brought in 82% of the revenue Aveanna Healthcare Holdings, Inc. broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2024 | 2025 |
|---|---|---|
| Private Duty Services | $1.6B | $2.0B |
| Home Health And Hospice | $217.8M | $248.6M |
| Medical Solutions | $172.1M | $183.5M |
Where the money goes
Where each dollar of revenue went, fiscal 2026
- Selling, general and admin15¢$374.5M
- Other costs65¢$1.6B
- Interest6¢$140.1M
- Income tax5¢$118.1M
- Profit9¢$225.0M
Out of $2.4B in revenue.3
Where each dollar of operating cash went, fiscal 2026
- Kept or used elsewhere100¢$125.9M
Out of $125.9M of cash from operations.3
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | $2.4B | $2.0B |
| Cost of revenue, excluding depreciation and amortization | $1.6B | $1.4B |
| Branch and regional administrative expenses | $374.5M | $352.8M |
| Corporate expenses | $163.3M | $125.4M |
| Depreciation and amortization | $10.5M | $10.8M |
| Acquisition-related costs | $3.8M | $1.5M |
| Other operating expense | $1.9M | $5.3M |
| Operating income | $256.5M | $139.8M |
| Interest income | $2.8M | $498.0K |
| Interest expense | -$140.1M | -$156.6M |
| Loss on debt extinguishment | -$5.9M | $0 |
| Other (expense) income | -$6.4M | $21.4M |
| Income before income taxes | $106.9M | $5.1M |
| Income tax benefit (expense) | $118.1M | -$16.0M |
| Net income (loss) | $225.0M | -$10.9M |
| Net income (loss) per share, basic | $1.11 | -$0.06 |
| Weighted average shares of common stock outstanding, basic | 203.5M shares | 192.9M shares |
| Net income (loss) per share, diluted | $1.05 | -$0.06 |
| Weighted average shares of common stock outstanding, diluted | 215.0M shares | 192.9M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $193.3M | $84.3M | |
| Patient accounts receivable | $313.4M | $265.2M | |
| Receivables under insured programs | $2.8M | $12.5M | |
| Prepaid expenses | $20.9M | $17.5M | |
| Other current assets | $29.9M | $13.2M | |
| Total current assets | $560.2M | $392.7M | |
| Property and equipment, net | $16.7M | $17.4M | |
| Operating lease right of use assets | $39.0M | $41.3M | |
| Goodwill | $1.1B | $1.1B | $1.1B |
| Intangible assets, net | $92.6M | $89.6M | |
| Receivables under insured programs | $28.8M | $22.4M | |
| Deferred income taxes | $137.1M | ||
| Other long-term assets | $16.9M | $45.5M | |
| Total assets | $2.0B | $1.7B | |
| Accounts payable and other accrued liabilities | $32.0M | $36.4M | |
| Accrued payroll and employee benefits | $108.1M | $87.7M | |
| Current portion of insurance reserves - insured programs | $2.8M | $12.5M | |
| Current portion of insurance reserves | $17.2M | $18.4M | |
| Securitization obligations | $165.0M | $168.8M | |
| Current portion of long-term obligations | $13.2M | $9.2M | |
| Current portion of operating lease liabilities | $16.0M | $15.5M | |
| Other current liabilities | $70.2M | $53.7M | |
| Total current liabilities | $424.5M | $402.2M | |
| Long-term obligations, less current portion | $1.3B | $1.3B | |
| Long-term insurance reserves - insured programs | $28.8M | $22.4M | |
| Long-term insurance reserves | $49.1M | $44.5M | |
| Operating lease liabilities, less current portion | $27.4M | $31.7M | |
| Deferred income taxes | $5.9M | ||
| Other long-term liabilities | $800.0K | $7.1M | |
| Total liabilities | $1.8B | $1.8B | |
| Deferred restricted stock units | $730.0K | $1.5M | |
| Common stock, $0.01 par value, 1,000,000,000 shares authorized; 210,996,359 and 193,225,177 issued and outstanding, respectively | $2.1M | $1.9M | |
| Additional paid-in capital | $1.3B | $1.3B | |
| Accumulated deficit | -$1.2B | -$1.4B | |
| Total stockholders' equity (deficit) | $194.5M | -$123.6M | -$129.6M |
| Total liabilities, deferred restricted stock units, and stockholders' equity (deficit) | $2.0B | $1.7B | |
| Preferred stock, par value | $0.01 | $0.01 | |
| Preferred stock, authorized | 5.0M shares | 5.0M shares | |
| Preferred stock, issued | 0 shares | 0 shares | |
| Preferred stock,outstanding | 0 shares | 0 shares | |
| Common stock, par value | $0.01 | $0.01 | |
| Common stock, authorized | 1.0B shares | 1.0B shares | |
| Common stock, issued | 211.0M shares | 193.2M shares | |
| Common stock, outstanding | 211.0M shares | 193.2M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $193.3M | $84.3M | |
| Patient accounts receivable | $313.4M | $265.2M | |
| Receivables under insured programs | $2.8M | $12.5M | |
| Prepaid expenses | $20.9M | $17.5M | |
| Other current assets | $29.9M | $13.2M | |
| Total current assets | $560.2M | $392.7M | |
| Property and equipment, net | $16.7M | $17.4M | |
| Operating lease right of use assets | $39.0M | $41.3M | |
| Goodwill | $1.1B | $1.1B | $1.1B |
| Intangible assets, net | $92.6M | $89.6M | |
| Receivables under insured programs | $28.8M | $22.4M | |
| Deferred income taxes | $137.1M | ||
| Other long-term assets | $16.9M | $45.5M | |
| Total assets | $2.0B | $1.7B | |
| Accounts payable and other accrued liabilities | $32.0M | $36.4M | |
| Accrued payroll and employee benefits | $108.1M | $87.7M | |
| Current portion of insurance reserves - insured programs | $2.8M | $12.5M | |
| Current portion of insurance reserves | $17.2M | $18.4M | |
| Securitization obligations | $165.0M | $168.8M | |
| Current portion of long-term obligations | $13.2M | $9.2M | |
| Current portion of operating lease liabilities | $16.0M | $15.5M | |
| Other current liabilities | $70.2M | $53.7M | |
| Total current liabilities | $424.5M | $402.2M | |
| Long-term obligations, less current portion | $1.3B | $1.3B | |
| Long-term insurance reserves - insured programs | $28.8M | $22.4M | |
| Long-term insurance reserves | $49.1M | $44.5M | |
| Operating lease liabilities, less current portion | $27.4M | $31.7M | |
| Deferred income taxes | $5.9M | ||
| Other long-term liabilities | $800.0K | $7.1M | |
| Total liabilities | $1.8B | $1.8B | |
| Deferred restricted stock units | $730.0K | $1.5M | |
| Common stock, $0.01 par value, 1,000,000,000 shares authorized; 210,996,359 and 193,225,177 issued and outstanding, respectively | $2.1M | $1.9M | |
| Additional paid-in capital | $1.3B | $1.3B | |
| Accumulated deficit | -$1.2B | -$1.4B | |
| Total stockholders' equity (deficit) | $194.5M | -$123.6M | -$129.6M |
| Total liabilities, deferred restricted stock units, and stockholders' equity (deficit) | $2.0B | $1.7B | |
| Preferred stock, par value | $0.01 | $0.01 | |
| Preferred stock, authorized | 5.0M shares | 5.0M shares | |
| Preferred stock, issued | 0 shares | 0 shares | |
| Preferred stock,outstanding | 0 shares | 0 shares | |
| Common stock, par value | $0.01 | $0.01 | |
| Common stock, authorized | 1.0B shares | 1.0B shares | |
| Common stock, issued | 211.0M shares | 193.2M shares | |
| Common stock, outstanding | 211.0M shares | 193.2M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income (loss) | $225.0M | -$10.9M |
| Depreciation and amortization | $10.5M | $10.8M |
| Amortization of deferred debt issuance costs | $5.9M | $5.5M |
| Reduction in carrying amount of operating lease right of use assets | $17.7M | $20.4M |
| Non-cash share-based compensation | $25.1M | $17.5M |
| Loss on disposal or impairment of licenses, property and equipment, and software | $1.9M | $3.2M |
| Fair value adjustments on interest rate derivatives | $29.7M | $15.2M |
| Loss on debt extinguishment | $5.9M | $0 |
| Deferred income taxes | -$143.0M | $1.0M |
| Patient accounts receivable | -$30.2M | -$28.6M |
| Prepaid expenses | $6.5M | $6.0M |
| Other current and long-term assets | -$26.8M | -$20.6M |
| Accounts payable and other accrued liabilities | -$6.2M | $6.4M |
| Accrued payroll and employee benefits | $15.7M | $20.5M |
| Insurance reserves | $2.2M | $1.7M |
| Operating lease liabilities | -$19.3M | -$19.6M |
| Other current and long-term liabilities | $5.5M | $4.2M |
| Net cash provided by operating activities | $125.9M | $32.6M |
| Acquisitions of businesses, net of cash acquired | -$14.9M | $0 |
| Purchases of property and equipment, and software | -$7.4M | -$6.3M |
| Net cash used in investing activities | -$22.3M | -$6.3M |
| Payments for shares withheld to cover employee taxes on vesting of restricted stock | -$6.3M | $0 |
| Proceeds from exercise of options | $212.0K | $0 |
| Proceeds from employee stock purchase plan | $6.3M | $3.1M |
| Proceeds from securitization obligation | $0 | $25.0M |
| Repayment of securitization obligation | -$3.8M | -$11.2M |
| Proceeds from issuance of term loans, net of debt issuance costs | $1.3B | $0 |
| Principal payments on term loans | -$1.3B | -$9.2M |
| Principal payments on notes payable | -$8.9M | -$6.6M |
| Principal payments on financing lease obligations | $0 | -$267.0K |
| Payment of debt issuance costs | -$3.6M | -$2.2M |
| Settlements with interest rate swap counterparties | $12.6M | $15.5M |
| Net cash provided by financing activities | $5.4M | $14.0M |
| Net change in cash and cash equivalents | $109.0M | $40.3M |
| Cash paid for interest | $143.1M | $152.5M |
| U.S. Federal | $24.5M | |
| California | $2.9M | |
| Other State and Local | $3.4M | |
| Foreign | $0 | |
| Total Cash paid for income taxes, net of refunds received | $30.8M | $5.7M |
| Financed insurance premiums | $9.2M | $7.8M |
No quarter-by-quarter statement was filed.
Compare Aveanna Healthcare Holdings, Inc. with another company
Corporate structure
Aveanna Healthcare Holdings, Inc. sits at the top of its group. 119 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Aveanna Healthcare Holdings, Inc.
- J.H. Whitney VII, L.P. Filed SCHEDULE 13G/A on Aveanna Healthcare Holdings, Inc., latest Aug 3, 2026 (6 filings since Feb 14, 2022)
- Nut Tree Capital Management, LP Filed SC 13G on Aveanna Healthcare Holdings, Inc., latest Feb 14, 2024
- BCPE Eagle Investor, LP Filed SC 13G on Aveanna Healthcare Holdings, Inc., latest Feb 14, 2022
- Aveanna Healthcare Holdings, Inc. Atlanta, Georgia, United States
- 5 Star Home Health Services, LLC Subsidiary · Florida, United States
- AB Innovations Health Services Incorporated Subsidiary · Texas, United States
- Accredited FMS, Inc. Subsidiary · California, United States
- Accredited Respite Services, Inc. Subsidiary · California, United States
- Advocate Pediatric Home Care, LLC Subsidiary · Texas, United States
- American Staffing Services, Inc. Subsidiary · Pennsylvania, United States
- AndVenture, LLC Subsidiary · Pennsylvania, United States
- Angel's Touch Home Care, LLC Subsidiary · Pennsylvania, United States
- Assure Home Healthcare, Inc. Subsidiary · Texas, United States
- Aveanna Healthcare AS, LLC Subsidiary · Delaware, United States
- Aveanna Healthcare Intermediate Holdings LLC Subsidiary · Delaware, United States
- Aveanna Healthcare Senior Services LLC Subsidiary · Delaware, United States
- Aveanna SPV I, LLC Subsidiary · Delaware, United States
- Aveanna Staffing Services, LLC Subsidiary · Delaware, United States
- Barry & Taffy, Inc. Subsidiary · California, United States
- Berger, Inc. Subsidiary · California, United States
- Care America Home Care Services, Inc. Subsidiary · Pennsylvania, United States
- Care Unlimited, Inc. Subsidiary · Pennsylvania, United States
- Child's Play Therapeutic Homecare Inc Subsidiary · Texas, United States
- Comfort Care Coastal Home Health, LLC Subsidiary · Alabama, United States
- Comfort Care Coastal Hospice, LLC Subsidiary · Alabama, United States
- Comfort Care Home Health of North Alabama, LLC Subsidiary · Alabama, United States
- Comfort Care Home Health of Northeast Alabama, LLC Subsidiary · Alabama, United States
- Comfort Care Home Health of West Alabama, LLC Subsidiary · Alabama, United States
- Comfort Care Home Health Services, LLC Subsidiary · Alabama, United States
- and 93 more
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Aveanna Healthcare Holdings, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $106.9M3 Jan 3, 2026 | $98.0M3 Dec 28, 2024 | +9.1% |
| Accumulated depreciation | $90.3M3 Jan 3, 2026 | $80.6M3 Dec 28, 2024 | +12.0% |
| Property and equipment, net | $16.7M3 Jan 3, 2026 | $17.4M3 Dec 28, 2024 | −4.1% |
| Operating-lease assets (leased space) | $39.0M3 Jan 3, 2026 | $41.3M3 Dec 28, 2024 | −5.4% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $193.3M3 Jan 3, 2026 | $84.3M3 Dec 28, 2024 | +129.3% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $1.1B3 Jan 3, 2026 | $1.1B3 Dec 28, 2024 | +6.3% |
| Intangible assets, net (excluding goodwill) | $92.6M3 Jan 3, 2026 | $89.6M3 Dec 28, 2024 | +3.3% |
| Indefinite-lived intangibles (excluding goodwill) | $88.4M3 Jan 3, 2026 | $85.2M3 Dec 28, 2024 | +3.7% |
| Finite-lived intangibles, gross | $39.6M3 Jan 3, 2026 | $39.1M3 Dec 28, 2024 | +1.4% |
| Accumulated amortization | $35.5M3 Jan 3, 2026 | $34.8M3 Dec 28, 2024 | +2.0% |
| Finite-lived intangibles, net | $4.2M3 Jan 3, 2026 | $4.3M3 Dec 28, 2024 | −3.7% |
Properties, in its own words
Aveanna’s corporate headquarters is leased and is located at 400 Interstate North Parkway SE, Suite 1600, Atlanta, Georgia 30339. Aveanna also maintains approximately 300 leases for other offices and medical sites with various expiration terms from more than one year to over 10 years. Aveanna does not currently own any real estate.
Item 2 of the 10-K filed Mar 19, 2026.6
Leadership
Who has led Aveanna Healthcare Holdings, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
2025
- Chief executive officerJeff Shaner Feb 16, 2023 to now13
- Chief executive officerTony Strange Apr 28, 2021 to Apr 28, 202114
- ChairRodney D. Windley Apr 28, 2021 to Aug 5, 202215
- Chief financial officerMatthew Buckhalter Feb 23, 2024 to now16
- Chief financial officerDavid Afshar Apr 28, 2021 to Feb 16, 202317
- Chief operating officerJeff Shaner Apr 28, 2021 to May 20, 202218
Board members and other officers (20)
- OfficerJeff Shaner Feb 23, 2024 to now19
- OfficerJerry Perchik Apr 30, 2024 to Apr 30, 202420
- SVP, Chief Accounting OfficerDeborah Stewart Jul 14, 2023 to now21
- OfficerMatthew Buckhalter Jul 14, 2023 to Jul 14, 202322
- Chief Clinical OfficerBeth Rubio Apr 28, 2021 to Feb 16, 202323
- Chief Administrative OfficerEdwin C. Reisz Apr 28, 2021 to now24
- OfficerShannon Drake Apr 28, 2021 to Feb 16, 202325
- OfficerTony Strange Dec 17, 2021 to Aug 5, 202226
- Board memberSamuel Altman Weil Mar 18, 2026 to now27
- Board memberJeff Shaner Feb 19, 2025 to now28
- Board memberBrent D. Layton Nov 14, 2024 to now29
- Board memberRodney D. Windley Feb 16, 2023 to now30
- Board memberChristopher R. Gordon Apr 28, 2021 to Apr 28, 202131
- Board memberRichard C. Zoretic Apr 28, 2021 to Feb 23, 202432
- Board memberSheldon M. Retchin Apr 28, 2021 to now33
- Board memberSteven E. Rodgers Apr 28, 2021 to now34
- Board memberT. Devin O'Reilly Apr 28, 2021 to Apr 28, 202135
- Board memberTony Strange Apr 28, 2021 to Aug 5, 202214
- Board memberVictor F. Ganzi Apr 28, 2021 to now36
- General counselJerry Perchik Mar 4, 2025 to now37
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- 5 Star Home Health Services, LLC Florida5
- AB Innovations Health Services Incorporated Texas5
- Accredited FMS, Inc. California5
- Accredited Respite Services, Inc. California5
- Advocate Pediatric Home Care, LLC Texas5
- American Staffing Services, Inc. Pennsylvania5
- AndVenture, LLC Pennsylvania5
- Angel's Touch Home Care, LLC Pennsylvania5
- Assure Home Healthcare, Inc. Texas5
- Aveanna Healthcare AS, LLC Delaware5
- Aveanna Healthcare Intermediate Holdings LLC Delaware5
- Aveanna Healthcare LLC Delaware5
- Aveanna Healthcare Senior Services LLC Delaware5
- Aveanna SPV I, LLC Delaware5
- Aveanna Staffing Services, LLC Delaware5
- Barry & Taffy, Inc. California5
- Berger, Inc. California5
- Care America Home Care Services, Inc. Pennsylvania5
- Care Unlimited, Inc. Pennsylvania5
- Child's Play Therapeutic Homecare Inc Texas5
- Comfort Care Coastal Home Health, LLC Alabama5
- Comfort Care Coastal Hospice, LLC Alabama5
- Comfort Care Home Health Services, LLC Alabama5
- Comfort Care Home Health of North Alabama, LLC Alabama5
All 120 listed subsidiaries
- Comfort Care Home Health of Northeast Alabama, LLC Alabama5
- Comfort Care Home Health of West Alabama, LLC Alabama5
- Comfort Care Hospice of Middle Tennessee, LLC Tennessee5
- Comfort Care Hospice, L.L.C. Alabama5
- D & D Services, Inc. Oklahoma5
- DM Holdco, Inc. Delaware5
- Dawson Thomas, Inc. Colorado5
- Dependable Nurses of Phoenix, LLC Delaware5
- Doctor’s Choice Holdings, LLC Delaware5
- Doctor’s Choice Home Care, LLC Florida5
- Dunn & Berger, Inc. California5
- EHS DE Holdings, Inc. Delaware5
- Epic Acquisition, Inc. Delaware5
- Epic Health Services (DE), LLC Delaware5
- Epic Health Services (PA), LLC Pennsylvania5
- Epic Health Services, Inc. Texas5
- Epic Pediatric Therapy, L.P. Texas5
- Evergreen Home Healthcare, LLC Colorado5
- FHH Holdings, Inc. Delaware5
- First Choice Children's Homecare, LP Texas5
- Firstaff Nursing Services, Inc. Pennsylvania5
- Five Points Healthcare of Alabama, LLC Delaware5
- Five Points Healthcare of DE, LLC Delaware5
- Five Points Healthcare of GA, LLC Delaware5
- Five Points Healthcare of Louisiana, LLC Delaware5
- Five Points Healthcare of NC, LLC Delaware5
- Five Points Healthcare of PA, LLC Delaware5
- Five Points Healthcare of Virginia, LLC Delaware5
- Five Points Healthcare, LLC Delaware5
- Florida Homecare Specialists of Citrus LLC Florida5
- Freedom Eldercare NY, Inc. New York5
- Freedom Home Healthcare, Inc. Delaware5
- Health & Home Services Management Company, Inc. North Carolina5
- Health & Home Services, Inc. North Carolina5
- Home Health Care of Northern Nevada, LLC Nevada5
- HomeFirst Healthcare Services, LLC. North Carolina5
- JED ADAM Enterprises, LLC Nevada5
- LCA Holding, Inc. Delaware5
- Loving Care Agency, Inc. New Jersey5
- Medco Respiratory Instruments, Incorporated Texas5
- Millenium Home Health Care, Inc. Pennsylvania5
- Nurses To Go, LLC Missouri5
- Nursing Plus, LLC Florida5
- Option 1 Billing Group, LLC Arizona5
- Option 1 Northwest Enteral, LLC Washington5
- Option 1 Nutrition Group, LLC Delaware5
- Option 1 Nutrition Holdings, Inc. Delaware5
- Option 1 Nutrition Solutions CA, Inc. California5
- Option 1 Nutrition Solutions, LLC Colorado5
- P&H Healthcare Solutions, LLC Texas5
- PSA Healthcare Intermediate Holding, LLC Delaware5
- PYRA Med Health Services, LLC Texas5
- Pediatria HealthCare LLC Delaware5
- Pediatric Home Care, Inc. Washington5
- Pediatric Home Health Care Holdings, Inc. Delaware5
- Pediatric Home Nursing Services, Inc. New York5
- Pediatric Services Holding, LLC Delaware5
- Pediatric Services of America, LLC Georgia5
- Pediatric Special Care, Inc. Michigan5
- Pennhurst Group, LLC Nevada5
- Premier Healthcare Services, LLC California5
- Premier Medical Housecall, LLC Alabama5
- Recover Health Services, LLC Minnesota5
- Recover Health of Iowa, Inc. Iowa5
- Recover Health of Minnesota, Inc. Minnesota5
- Recover Health of Wisconsin, Inc. Wisconsin5
- Recover Health, Inc. Florida5
- Rehabilitation Associates, Inc. Virginia5
- SLHHA Holdings, LLC Florida5
- SP GE IX-B Thrive Blocker Corp. Delaware5
- Saints Home Healthcare, LLC Delaware5
- Santé GP, LLC Delaware5
- Santé Holdings, Inc. Delaware5
- Saving Lives Home Health Agency, LLC Florida5
- ShepherdCare Hospice, LLC Georgia5
- Simone Health Care, LLC Florida5
- SoftTouch Medical Holdings LLC Delaware5
- SoftTouch Medical, LLC Georgia5
- TCG Home Health, LLC Texas5
- TCGHHA, LLC Texas5
- THS Services, LLC North Carolina5
- TSPC Services-VA, LLC Delaware5
- TSPC-GA, LLC Delaware5
- TSPC-KS, LLC Delaware5
- TSPC-NM, LLC Delaware5
- TSPC-NV, LLC Delaware5
- TSPC-TN, LLC Delaware5
- TSPC-TX, LLC Delaware5
- The Pediatric Connection, Inc. Virginia5
- Thrive DME-TX, LLC Delaware5
- Thrive Skilled Pediatric Care, LLC Delaware5
- Timeless Home Care, LLC Florida5
- Total Care, Inc. Washington5
- Willowbrook Health Systems, Inc. Tennessee5
- Willowbrook Home Health Care Agency, Inc. Tennessee5
- Willowbrook Hospice, Inc. Tennessee5
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Timeline
- Oct 2, 20268-K Executive or director change38
- Aug 24, 20268-K Other events39
- Aug 13, 20268-K Results of operations; Regulation FD disclosure40
- Aug 13, 20268-K Regulation FD disclosure41
- Aug 7, 20268-K Executive or director change42
- Jun 2, 20268-K Other events43
- May 29, 20268-K Shareholder vote44
- May 28, 20268-K Other events45
- May 15, 20268-K Regulation FD disclosure46
- May 14, 20268-K Results of operations; Regulation FD disclosure47
- Mar 20, 20268-K Regulation FD disclosure48
- Mar 19, 20268-K Results of operations; Regulation FD disclosure49
- Feb 16, 2023New chief executive Jeff Shaner becomes CEO13
- Apr 28, 2021New chief executive Tony Strange becomes CEO14
Calendar
Coming up
- Nov 5, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported $0.12 a share, on Nov 6, 2025.50
When it reported results
- Aug 13, 2026Reported quarterly or annual results40
- May 14, 2026Reported quarterly or annual results47
- Mar 19, 2026Reported quarterly or annual results49
- Jan 14, 2026Reported quarterly or annual results51
- Nov 6, 2025Reported quarterly or annual results52
- Oct 21, 2025Reported quarterly or annual results53
- Aug 7, 2025Reported quarterly or annual results54
- May 8, 2025Reported quarterly or annual results55
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
354 filings to the SEC since October 2021: 5 annual reports, 16 quarterly reports, 73 major events, 177 insider forms, 8 large holders, 75 other. The latest 20:
- Oct 5, 20264 EDGAR
- Oct 2, 20268-K EDGAR
- Sep 9, 2026144 EDGAR
- Aug 27, 2026144 EDGAR
- Aug 24, 20264 EDGAR
- Aug 24, 20264 EDGAR
- Aug 24, 20264 EDGAR
- Aug 24, 20264 EDGAR
- Aug 24, 20264 EDGAR
- Aug 24, 20264 EDGAR
- Aug 24, 20268-K EDGAR
- Aug 24, 2026424B4 EDGAR
- Aug 20, 2026424B4 EDGAR
- Aug 13, 202610-Q EDGAR
- Aug 13, 20268-K EDGAR
- Aug 13, 20268-K EDGAR
- Aug 7, 20268-K EDGAR
- Aug 3, 2026SCHEDULE 13G/A EDGAR
- Jul 2, 20264 EDGAR
- Jul 2, 20264 EDGAR
The 354 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
117 open-market trades by officers, directors and large owners since October 2021: 17 buys and 100 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 21, 2026 | J.H. Whitney Equity Partners VII, LLC10% owner | Sale | 2,250,000 | $11.50 | $25.9M | Form 4 |
| Aug 21, 2026 | WILLIAMS ROBERT M JR10% owner | Sale | 2,250,000 | $11.50 | $25.9M | Form 4 |
| Aug 21, 2026 | VIGANO PAUL R10% owner | Sale | 2,250,000 | $11.50 | $25.9M | Form 4 |
| Aug 20, 2026 | J.H. Whitney Equity Partners VII, LLC10% owner | Sale | 12,496,077 | $11.50 | $143.7M | Form 4 |
| Aug 20, 2026 | WILLIAMS ROBERT M JR10% owner | Sale | 14,500,002 | $11.50 | $166.8M | Form 4 |
| Aug 20, 2026 | VIGANO PAUL R10% owner | Sale | 14,500,002 | $11.50 | $166.8M | Form 4 |
| Aug 20, 2026 | Windley Rodney DDirector | Sale | 180,000 | $11.50 | $2.1M | Form 4 |
| Aug 20, 2026 | Shaner JeffChief Executive Officer | Sale | 90,000 | $11.50 | $1.0M | Form 4 |
| Aug 20, 2026 | Reisz Edwin C.Chief Administrative Officer | Sale | 50,000 | $11.50 | $575.0K | Form 4 |
| Jun 30, 2026 | WILLIAMS ROBERT M JR10% owner | Sale | 3,000,000 | $8.01 | $24.0M | Form 4 |
| Jun 30, 2026 | VIGANO PAUL R10% owner | Sale | 3,000,000 | $8.01 | $24.0M | Form 4 |
| Jun 30, 2026 | J.H. Whitney Equity Partners VII, LLC10% owner | Sale | 2,419,035 | $8.01 | $19.4M | Form 4 |
| Jun 24, 2026 | WILLIAMS ROBERT M JR10% owner | Sale | 1,000,000 | $8.00 | $8.0M | Form 4 |
| Jun 24, 2026 | J.H. Whitney Equity Partners VII, LLC10% owner | Sale | 919,389 | $8.00 | $7.4M | Form 4 |
| Jun 24, 2026 | VIGANO PAUL R10% owner | Sale | 1,000,000 | $8.00 | $8.0M | Form 4 |
| Jun 3, 2026 | VIGANO PAUL R10% owner | Sale | 7,000,000 | $6.24 | $43.7M | Form 4 |
| Jun 3, 2026 | WILLIAMS ROBERT M JR10% owner | Sale | 7,000,000 | $6.24 | $43.7M | Form 4 |
| Jun 3, 2026 | J.H. Whitney Equity Partners VII, LLC10% owner | Sale | 5,842,240 | $6.24 | $36.5M | Form 4 |
| May 20, 2026 | Cunningham Patrick A.Chief Compliance Officer | Sale | 125,000 | $7.59 | $948.8K | Form 4 |
| Feb 19, 2026 | Shaner JeffChief Executive Officer | Sale | 173,225 | $7.21 | $1.2M | Form 4 |
All 117 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- J.H. Whitney VII, L.P.SCHEDULE 13G/A, 6 filings Feb 14, 2022 to Aug 3, 202656
- Nut Tree Capital Management, LPSC 13G, 1 filing Feb 14, 202457
- BCPE Eagle Investor, LPSC 13G, 1 filing Feb 14, 202258
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Jeffrey Shaner | 53 | $750.0K | $4.9M59 |
| 2025 | Ed Reisz | 67 | $450.0K | $2.0M59 |
| 2025 | Matthew Buckhalter | 37 | $468.8K | $1.9M59 |
| 2024 | Chief Executive Officer (PEO) | $750.0K | $4.5M59 | |
| 2024 | Chief Financial Officer (PFO) | $425.0K | $1.7M59 | |
| 2024 | Chief Administrative Officer | $450.0K | $1.6M59 |
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Bain Capital Investors LLC | 81,600,880 | $699.3M | 14.5% | No change |
| J.H. Whitney Equity Partners VII, LLC | 27,061,967 | $231.9M | 100.0% | −9,180,664 |
| Nut Tree Capital Management, LP | 12,922,649 | $110.7M | 26.4% | No change |
| BlackRock, Inc. | 7,410,053 | $63.5M | 0.0% | +1,909,141 |
| Ophir Asset Management Pty Ltd | 5,100,000 | $43.7M | 3.6% | New |
| Vanguard Capital Management LLC | 3,673,218 | $31.5M | 0.0% | −301,601 |
| Braidwell LP | 3,065,106 | $26.3M | 1.0% | +861,600 |
| Boston Partners | 2,870,979 | $24.9M | 0.0% | +46,905 |
| Citadel Advisors LLC | 2,285,756 | $19.6M | 0.0% | +2,008,806 |
| Dimensional Fund Advisors LP | 2,257,684 | $19.3M | 0.0% | +923,310 |
| Mackenzie Financial Corp | 2,107,505 | $18.1M | 0.0% | +1,584,319 |
| Geode Capital Management, LLC | 2,063,737 | $17.7M | 0.0% | +350,441 |
| State Street Corp | 1,951,640 | $16.7M | 0.0% | +391,645 |
| Assenagon Asset Management S.A. | 1,820,784 | $15.6M | 0.0% | +869,190 |
| Point72 Asset Management, L.P. | 1,803,451 | $15.5M | 0.0% | +1,702,795 |
| Arrowstreet Capital, Limited Partnership | 1,672,672 | $14.3M | 0.0% | +861,417 |
| Emerald Advisers, LLC | 1,642,406 | $14.1M | 0.3% | −48,051 |
| Algert Global LLC | 1,610,747 | $13.8M | 0.2% | −184,133 |
| Nuveen, LLC | 1,565,047 | $13.4M | 0.0% | −629,736 |
| Fmr LLC | 1,537,259 | $13.2M | 0.0% | +1,171,515 |
| First Eagle Investment Management, LLC | 1,529,334 | $13.1M | 0.0% | +762,667 |
| Jpmorgan Chase & Co | 1,504,013 | $13.0M | 0.0% | +1,050,546 |
| Vanguard Portfolio Management LLC | 1,393,499 | $11.9M | 0.0% | +170,450 |
| Morgan Stanley | 1,274,034 | $10.9M | 0.0% | −269,035 |
| Two Sigma Investments, LP | 1,192,169 | $10.2M | 0.0% | −175,269 |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How Aveanna Healthcare Holdings, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARAveanna Healthcare Holdings, Inc.1
- CIK0001832332
- Employer ID (EIN)81-47172096
- Filer statusAccelerated filer not an emerging growth company; not a smaller reporting company; not a shell company6
- Incorporated inDelaware6
- Fiscal year endsJanuary 11
- Industry code (SIC)8082 Services-Home Health Care Services1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address400 Interstate North Parkway, Ste 1700, Atlanta, GA 303391
- Phone770-441-15801
- Shares outstanding218,219,696 as of Aug 7, 202611
- Public float$349.7M as of Jun 28, 20256
- AuditorErnst & Young LLP, Atlanta, Georgia PCAOB ID 42; it also attests to the company’s internal control over financial reporting6
- On EDGAR sinceDec 11, 20201
- Filings411 in all: 4 (178), 8-K (76), 144 (39), 3 (24), 10-Q (17), S-8 (10), CORRESP (8), UPLOAD (7)1
All 30 form types
10-K (5), 424B4 (5), DEF 14A (5), DEFA14A (5), SCHEDULE 13G/A (5), ARS (4), 8-K/A (3), S-1/A (3), SC 13G (3), EFFECT (2), 10-Q/A (1), 4/A (1), 424B7 (1), 8-A12B (1), CERT (1), DRS (1), DRS/A (1), DRSLTR (1), PRE 14A (1), S-1 (1), S-3 (1), S-3/A (1)
- Latest filingsAnnual report (10-K) Mar 19, 2026
Quarterly report (10-Q) Aug 13, 2026
Proxy statement (DEF 14A) Apr 17, 2026
Latest 8-K (8-K) Oct 2, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, par value $0.01 per share | AVAH | The Nasdaq Stock Market LLC |
From the cover page of the 10-K filed Mar 19, 2026 (Section 12(b) of the Exchange Act).6
Risk factors and legal proceedings
The risks Aveanna Healthcare Holdings, Inc. names in Item 1A of its 10-K filed Mar 19, 2026: 55 risks under these headings, as written.6
- Risks Related to Our Business and Industry
- Competition among home health, hospice and durable medical equipment companies is intense.
- If we are unable to maintain relationships with existing patient referral sources, our business and consolidated financial condition, results of operations and cash flows could be materially adversely affected.
- The cost of healthcare is funded substantially by government and private insurance programs. If such funding is reduced or limited or no longer available, our business may be adversely impacted.
- Changes to Medicare and Medicaid rates or methods governing Medicare and Medicaid payments for our services could materially adversely affect our business.
- The implementation of alternative payment models and the transition of Medicaid and Medicare beneficiaries to managed care organizations may limit our market share and could adversely affect our revenues.
- Because we are limited in our ability to control reimbursement rates received for our services, our business could be materially adversely affected if we are not able to maintain or reduce our costs to provide such services.
- The industry trend toward value-based purchasing may impact our financial results negatively.
- Delays in collection or non-collection of our patient accounts receivable, or recoupment of payments previously received, particularly during the business integration process, or during system transitions, or in connection with complying with EVV data collection and submission requirements, could adversely affect our business, financial position, results of operations and liquidity.
- Failure to maintain the security and functionality of our information systems, or to defend against or otherwise prevent a cybersecurity attack or breach, could adversely affect our business, financial position, results of operations and liquidity.
- The use of technology based on artificial intelligence presents risks relating to confidentiality, creation of inaccurate and flawed outputs and emerging regulatory risk, any or all of which may adversely affect our business and results of operations.
- Healthcare reform and other regulations could adversely affect our customers, which could have an adverse effect on their ability to make timely payments to us for our products and services.
The other 44 risks
- Changes in the case-mix of our patients, as well as payer mix and payment methodologies, may have a material adverse effect on our profitability.
- If we are unable to provide consistently high quality of care, our business and consolidated financial condition, results of operations, and cash flows will be adversely impacted.
- Quality reporting requirements may negatively impact Medicare reimbursement.
- Our hospice operations are subject to annual Medicare caps. If any of our hospice providers exceeds such caps, our business and consolidated financial condition, results of operations, and cash flows could be materially adversely affected.
- Our failure to negotiate favorable managed care contracts, or our loss of existing favorable managed care contracts, could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows.
- Our business, financial condition and results of operations may be materially adversely affected by national public health emergencies, such as a pandemic or other infectious disease outbreak.
- The home health and hospice industries have historically experienced shortages in qualified employees and management, and competition for qualified personnel may increase our labor costs and reduce profitability.
- Any economic downturn, deepening of an economic downturn or federal and state budget pressures may result in a reduction in payments and covered services.
- Our business is dependent on the availability, integrity and security of internal and external information systems and IT services, but there are risks of business disruption associated with new business systems and technology initiatives.
- We develop and maintain portions of our clinical software systems in house. Failure of, or problems with, our systems could harm our business and operating results.
- If any of our home health or hospice agencies fail to comply with the conditions of participation in the Medicare program, that agency could be terminated from Medicare, which could adversely affect our results of operations and cash flow.
- We may not be able to adequately obtain and maintain our intellectual property and proprietary rights, which could impair our ability to protect and enforce intellectual property and our brand.
- We may become subject to intellectual property disputes, which could be costly and may subject us to significant liability and increased costs of doing business.
- We have substantial indebtedness, which will increase our vulnerability to general adverse economic and industry conditions and may limit our ability to pursue strategic alternatives and react to changes in our business and industry or pay dividends.
- If we are unable to extend the maturity date of our debt facilities as needed on a long-term basis, this could have a material adverse effect on our business.
- Our variable rate indebtedness subjects us to interest rate risk, which could cause our indebtedness service obligations to increase significantly.
- We may not be able to identify, acquire, successfully integrate and obtain financing for strategic and accretive acquisitions.
- Federal regulation may impair our ability to consummate acquisitions or open new branch locations.
- We are exposed to various risks related to legal proceedings, claims and governmental inquiries that could adversely affect our operating results. The nature of our business exposes us to various liability claims, which may exceed the level of our insurance coverage, meaning that our insurance may not fully protect us.
- Our balance sheet includes a significant amount of goodwill and intangible assets. An impairment in the carrying value of goodwill could negatively impact our consolidated results of operations and total assets.
- If we are unable to maintain our corporate reputation, or there is adverse publicity or changes in public perception of our services, our business may suffer.
- We are sensitive to regional weather conditions that may adversely affect our operations.
- We may be more vulnerable to the effects of a public health emergency than other businesses due to the nature of our patients, and any other unforeseen events may also disrupt our business.
- We depend on the services of our executive officers and other key employees.
- Our ability to use our net operating losses to offset future taxable income may be subject to certain limitations.
- Unanticipated changes in tax law or adverse outcomes resulting from examination of our income or other tax returns could adversely affect our consolidated results of operations, financial condition, and cash flows.
- Risks Related to Our Regulatory Framework
- Healthcare reform has initiated significant changes to the U.S. healthcare system.
- We conduct business in a heavily regulated industry, and changes in regulations, the enforcement of these regulations, or violations of regulations may result in increased costs or sanctions that reduce our revenues and profitability.
- Many states have CON laws or other regulatory provisions that may adversely impact our ability to expand into new markets and thereby limit our ability to grow and increase revenue.
- We face and are currently subject to reviews, audits and investigations under our contracts with federal and state government agencies and other payers, and these reviews, audits and investigations could have adverse findings that may negatively impact our business.
- We are subject to extensive and complex federal and state government laws and regulations that govern and restrict our relationships with physicians and other referral sources.
- If we are found to have violated HIPAA or any other applicable privacy and security laws and regulations, as well as contractual obligations, we could be subject to sanctions, fines, damages and other additional civil or criminal penalties, which could increase our liabilities, harm our reputation and have a material adverse effect on our business, financial position, results of operation and liquidity.
- We are subject to federal, state and local laws and regulations that govern our employment practices, including minimum wage, living wage, and paid time-off requirements. Failure to comply with these laws and regulations, or changes to these laws and regulations that increase our employment related expenses, could adversely impact our operations.
- Risks Related to Ownership of Our Common Stock
- You may be diluted by future issuances of additional shares of common stock in connection with our incentive plans, acquisitions or otherwise; future sales of such shares in the public market, or the expectations that such sales may occur, could lower our stock price.
- We may issue preferred stock whose terms could adversely affect the voting power or value of our common stock.
- We do not intend to pay dividends for the foreseeable future.
- We take advantage of certain “controlled company” exemptions to the corporate governance rules for publicly listed companies, which could make our common stock less attractive to some investors or otherwise harm our stock price.
- Our Sponsors can significantly influence our business and affairs and may have conflicts of interest with us in the future.
- If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, stockholders could lose confidence in our financial and other public reporting, which is likely to negatively affect our business and the market price of our common stock.
- Anti-takeover provisions in our governing documents and under Delaware law could make an acquisition of our company more difficult, limit attempts by our stockholders to replace or remove our current management and limit the market price of our common stock.
- Our Amended Charter designates specific courts as the exclusive forum for certain litigation that may be initiated by our stockholders, which could limit our stockholders’ abilities to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.
- Our Amended Charter provides that the doctrine of “corporate opportunity” does not apply with respect to any officer, director or stockholder who is not employed by us or our subsidiaries.
- If securities analysts do not publish research or reports about our company, or if they issue unfavorable commentary about us or our industry or downgrade our common stock, the price of our common stock could decline.
- If our operating and financial performance in any given period does not meet or exceed the guidance that we provide to the public, the market price of our common stock may decline.
Legal proceedings
The information in response to this Item is included in Note 14 – Commitments and Contingencies to the Consolidated Financial Statements, which information is incorporated by reference in this Item 3 of Part 1 of this Annual Report on Form 10-K.
The opening of Item 3, Legal Proceedings.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARJeff Shaner, Chief executive officer
- 14
- 15SEC EDGARRodney D. Windley, Chair
- 16
- 17
- 18SEC EDGARJeff Shaner, Chief operating officer
- 19SEC EDGARJeff Shaner, Officer
- 20SEC EDGARJerry Perchik, Officer
- 21
- 22SEC EDGARMatthew Buckhalter, Officer
- 23SEC EDGARBeth Rubio, Chief Clinical Officer
- 24
- 25SEC EDGARShannon Drake, Officer
- 26SEC EDGARTony Strange, Officer
- 27SEC EDGARSamuel Altman Weil, Board member
- 28SEC EDGARJeff Shaner, Board member
- 29SEC EDGARBrent D. Layton, Board member
- 30SEC EDGARRodney D. Windley, Board member
- 31SEC EDGARChristopher R. Gordon, Board member
- 32SEC EDGARRichard C. Zoretic, Board member
- 33SEC EDGARSheldon M. Retchin, Board member
- 34SEC EDGARSteven E. Rodgers, Board member
- 35SEC EDGART. Devin O'Reilly, Board member
- 36SEC EDGARVictor F. Ganzi, Board member
- 37SEC EDGARJerry Perchik, General counsel
- 38SEC EDGARExecutive or director change
- 39SEC EDGAROther events
- 40
- 41SEC EDGARRegulation FD disclosure
- 42SEC EDGARExecutive or director change
- 43SEC EDGAROther events
- 44SEC EDGARShareholder vote
- 45SEC EDGAROther events
- 46SEC EDGARRegulation FD disclosure
- 47
- 48SEC EDGARRegulation FD disclosure
- 49
- 50NasdaqNasdaq calendar
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59